Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 4/2016

01-04-2016 | Original Article

Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities

Authors: P. Vieira-Baptista, J. Lima-Silva, C. Pinto, C. Saldanha, J. Beires, J. Martinez-de-Oliveira, G. Donders

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 4/2016

Login to get access

Abstract

The purpose of this investigation was to evaluate the impact of the vaginal milieu on the presence of abnormal Pap smears and a positive human papilloma virus (HPV) test. A cross-sectional study was conducted between June 2014 and May 2015, evaluating the vaginal discharge by fresh wet mount microscopy and comparing these data with Pap smear findings. Wet mount slides were scored for bacterial vaginosis (BV), aerobic vaginitis (AV), presence of Candida and Trichomonas vaginalis. Cytologic evaluation was done on all Pap smears according to the Bethesda criteria. The cobas© HPV Test (Roche) was performed for HPV detection. A total of 622 cases were evaluated. The mean age of the patients was 41.6 ± 10.65 years (range 21–75). Eighty-three women (13.3 %) had a cytology result worse than low-grade squamous intraepithelial lesion (LSIL). When comparing this group with the one with normal or minor [atypical squamous cells of undetermined significance (ASC-US) or LSIL] Pap smear abnormalities, there were no differences in the presence of Candida (32.5 % vs. 33.2 %, p = 1.0), absence of lactobacilli (38.6 % vs. 32.5 %, p = 0.32) or BV (20.5 % vs. 13.2 %, p = 0.09). On the other hand, moderate or severe inflammation (msI) (41.0 % vs. 28.8 %, p = 0,04), moderate or severe AV (msAV) (16.9 % vs. 7.2 %, p = 0.009) and msAV/BV (37.3 % vs. 20.0 %, p = 0.001) were more common in women with such major cervical abnormalities. No significant association was found between deviations of the vaginal milieu and high-risk HPV infection. The presence of msI or msAV, but not BV, is independently associated with an increased risk of major cervical cytological abnormalities, but not with HPV infection.
Literature
16.
go back to reference Tansarli GS, Kostaras EK, Athanasiou S, Falagas ME (2013) Prevalence and treatment of aerobic vaginitis among non-pregnant women: evaluation of the evidence for an underestimated clinical entity. Eur J Clin Microbiol Infect Dis 32(8):977–984. doi:10.1007/s10096-013-1846-4 CrossRefPubMed Tansarli GS, Kostaras EK, Athanasiou S, Falagas ME (2013) Prevalence and treatment of aerobic vaginitis among non-pregnant women: evaluation of the evidence for an underestimated clinical entity. Eur J Clin Microbiol Infect Dis 32(8):977–984. doi:10.​1007/​s10096-013-1846-4 CrossRefPubMed
24.
go back to reference Donders GGG, Larsson PG, Platz-Christensen JJ, Hallén A, van der Meijden W, Wölner-Hanssen P (2009) Variability in diagnosis of clue cells, lactobacillary grading and white blood cells in vaginal wet smears with conventional bright light and phase contrast microscopy. Eur J Obstet Gynecol Reprod Biol 145(1):109–112. doi:10.1016/j.ejogrb.2009.04.012 CrossRefPubMed Donders GGG, Larsson PG, Platz-Christensen JJ, Hallén A, van der Meijden W, Wölner-Hanssen P (2009) Variability in diagnosis of clue cells, lactobacillary grading and white blood cells in vaginal wet smears with conventional bright light and phase contrast microscopy. Eur J Obstet Gynecol Reprod Biol 145(1):109–112. doi:10.​1016/​j.​ejogrb.​2009.​04.​012 CrossRefPubMed
26.
go back to reference Nayar R, Wilbur DC (2015) The Pap test and Bethesda 2014. “The reports of my demise have been greatly exaggerated.” (after a quotation from Mark Twain). Acta Cytol 59(2):121–132. doi:10.1159/000381842 CrossRefPubMed Nayar R, Wilbur DC (2015) The Pap test and Bethesda 2014. “The reports of my demise have been greatly exaggerated.” (after a quotation from Mark Twain). Acta Cytol 59(2):121–132. doi:10.​1159/​000381842 CrossRefPubMed
28.
go back to reference Mikamo H, Sato Y, Hayasaki Y et al (1999) Intravaginal bacterial flora in patients with uterine cervical cancer. High incidence of detection of Gardnerella vaginalis. J Infect Chemother 5(2):82–85. doi:10.1007/s101569900002 CrossRefPubMed Mikamo H, Sato Y, Hayasaki Y et al (1999) Intravaginal bacterial flora in patients with uterine cervical cancer. High incidence of detection of Gardnerella vaginalis. J Infect Chemother 5(2):82–85. doi:10.​1007/​s101569900002 CrossRefPubMed
31.
go back to reference Adefuye A, Sales K (2012) Regulation of inflammatory pathways in cancer and infectious disease of the cervix. Scientifica (Cairo) 2012, 548150. doi:10.6064/2012/548150 Adefuye A, Sales K (2012) Regulation of inflammatory pathways in cancer and infectious disease of the cervix. Scientifica (Cairo) 2012, 548150. doi:10.​6064/​2012/​548150
39.
go back to reference Mitchell A, Newton JM, Brite K et al (2007) Cyclooxygenase 2 expression in cervical intraepithelial neoplasia and vulvar cancer. J Low Genit Tract Dis 11(2):80–85CrossRefPubMed Mitchell A, Newton JM, Brite K et al (2007) Cyclooxygenase 2 expression in cervical intraepithelial neoplasia and vulvar cancer. J Low Genit Tract Dis 11(2):80–85CrossRefPubMed
42.
go back to reference Pabich WL, Fihn SD, Stamm WE, Scholes D, Boyko EJ, Gupta K (2003) Prevalence and determinants of vaginal flora alterations in postmenopausal women. J Infect Dis 188(7):1054–1058. doi:10.1086/378203 CrossRefPubMed Pabich WL, Fihn SD, Stamm WE, Scholes D, Boyko EJ, Gupta K (2003) Prevalence and determinants of vaginal flora alterations in postmenopausal women. J Infect Dis 188(7):1054–1058. doi:10.​1086/​378203 CrossRefPubMed
47.
go back to reference Güdücü N, Gönenç G, Işçi H, Yiğiter AB, Başsüllü N, Dünder I (2012) Clinical importance of detection of bacterial vaginosis, Trichomonas vaginalis, Candida albicans and actinomyces in papanicolaou smears. Clin Exp Obstet Gynecol 39(3):333–336. http://www.ncbi.nlm.nih.gov/pubmed/23157037. Accessed August 7, 2015PubMed Güdücü N, Gönenç G, Işçi H, Yiğiter AB, Başsüllü N, Dünder I (2012) Clinical importance of detection of bacterial vaginosis, Trichomonas vaginalis, Candida albicans and actinomyces in papanicolaou smears. Clin Exp Obstet Gynecol 39(3):333–336. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​23157037. Accessed August 7, 2015PubMed
50.
go back to reference Smith WL, Hedges SR, Mordechai E et al (2014) Cervical and vaginal flora specimens are highly concordant with respect to bacterial vaginosis-associated organisms and commensal lactobacillus species in women of reproductive age. J Clin Microbiol 52(8):3078–3081. doi:10.1128/JCM.00795-14 CrossRefPubMedPubMedCentral Smith WL, Hedges SR, Mordechai E et al (2014) Cervical and vaginal flora specimens are highly concordant with respect to bacterial vaginosis-associated organisms and commensal lactobacillus species in women of reproductive age. J Clin Microbiol 52(8):3078–3081. doi:10.​1128/​JCM.​00795-14 CrossRefPubMedPubMedCentral
51.
go back to reference Khatoon R, Jahan N, Ahmad S, Khan HM, Rabbani T (2015) Comparison of four diagnostic techniques for detection of Trichomonas vaginalis infection in females attending tertiary care hospital of North India. Indian J Pathol Microbiol 58(1):36–39. doi:10.4103/0377-4929.151172 CrossRefPubMed Khatoon R, Jahan N, Ahmad S, Khan HM, Rabbani T (2015) Comparison of four diagnostic techniques for detection of Trichomonas vaginalis infection in females attending tertiary care hospital of North India. Indian J Pathol Microbiol 58(1):36–39. doi:10.​4103/​0377-4929.​151172 CrossRefPubMed
Metadata
Title
Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities
Authors
P. Vieira-Baptista
J. Lima-Silva
C. Pinto
C. Saldanha
J. Beires
J. Martinez-de-Oliveira
G. Donders
Publication date
01-04-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 4/2016
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-016-2584-1

Other articles of this Issue 4/2016

European Journal of Clinical Microbiology & Infectious Diseases 4/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine